Jiangsu in Focus: Bridging History and the Future Through High-Quality Development
NANJING, China, Nov. 27, 2024 /PRNewswire/ -- "This is my first time in Jiangsu, and I loved the beautiful rural villages," Helena Kočova, a journalist from Czech Republic's Naše Pravda, said during her trip in Jiangsu. "The innovative approach to...
Gravity Announces Global Release of Tokyo Psychodemic
Available now on PlayStation®4, PlayStation®5, and Nintendo Switch™, with updated language support on Steam®. Digital versions are available for immediate download and play through the PlayStation Store and Nintendo eShop. SEOUL, South Korea, Nov....
Everest Medicines Announces NEFECON®, the World's First Approved Treatment for IgA Nephropathy, is Included in China's National Reimbursement Drug List
SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
Antengene Announces XPOVIO®'s New Indication Included in 2024 China National Reimbursement Drug List, Making the Drug More Accessible to DLBCL Patients in the Country
SHANGHAI and HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing...
ASSEMBLY ELEVATES VIVIAN MOK TO SVP & MANAGING DIRECTOR FOR NORTH ASIA
Mok will be pivotal in solidifying Assembly's proposition and accelerating the agency's growth in North Asia SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- Assembly, a leading global omnichannel media agency, announced today the promotion of...
Innovent Announces First-Time Inclusion of SINTBILO® and New Indication for Olverembatinib in China's National Reimbursement Drug List
SAN FRANCISCO and SUZHOU, China, Nov. 28, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of...
Team T5 Applauded by Frost & Sullivan for Deeply and Effectively Monitoring Regional Adversaries and Incidents
With offices in Taiwan and Japan, TeamT5 provides in-depth localized threat intelligence, especially for organizations targeted by Chinese adversaries. SAN ANTONIO, Nov. 28, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the threat...
Akeso Announced the Inclusion in China's National Reimbursement Drug List of Cadonilimab and Ivonescimab
HONG KONG, Nov. 28, 2024 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company") is pleased to announce that two of its independently developed, globally pioneering bispecific antibody drugs—cadonilimab Injection (PD-1/CTLA-4 bispecific...